Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.
A case of depressive psychosis associated with corticosteroid therapy for the treatment of Churg-Strauss syndrome is described. We outline the patient's response to different antidepressant and antipsychotic medications in this case. A significant improvement with low doses of Venlafaxine is open for further discussion and study.
Ismail
M
M
St Brigid's Hospital, Ardee, Co Louth. drismail@ireland.com
Lyster
G
G
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D015267:Churg-Strauss Syndrome / Q000188:drug therapy*; D003511:Cyclohexanols / Q000627:therapeutic use; D003863:Depression / Q000139:chemically induced* / Q000628:therapy; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D017374:Paroxetine / Q000627:therapeutic use; D018967:Risperidone / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D000305:Adrenal Cortex Hormones; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003511:Cyclohexanols; D017374:Paroxetine; D000069470:Venlafaxine Hydrochloride; D018967:Risperidone